deltatrials
Completed OBSERVATIONAL NCT04181190

Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients (BIONIGE)

Effects of Anti-IL5 Biological Treatments of Total Blood IgE Levels in Severe Asthmatic Patients: Real-life Retrospective Multicenter Observational Study

Sponsor: Università degli Studi di Ferrara

Updated 6 times since 2019 Last updated: Nov 3, 2020 Started: Oct 11, 2019 Primary completion: Oct 1, 2020 Completion: Nov 1, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Asthma and Asthma; Eosinophilic and is currently completed. Università degli Studi di Ferrara leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshotRecruiting~Mar 2020 – ~Dec 2020 · 9 months · monthly snapshotRecruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Dec 2020 — Jan 2021 [monthly]

    Completed

    Status: RecruitingCompleted

  5. Mar 2020 — Dec 2020 [monthly]

    Recruiting

Show 1 earlier version
  1. Dec 2019 — Mar 2020 [monthly]

    Recruiting

    First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Università degli Studi di Ferrara
Data source: Università degli Studi di Ferrara

For direct contact, visit the study record on ClinicalTrials.gov .